A2A Pharmaceuticals, Inc., 10% Owner at Biomea Fusion, Inc. (BMEA), bought 69,316 shares at $10.96 ($760K) on 2021-09-17, disclosed to the SEC on 2021-09-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.96 | 34,658 | $380K | 50.0% |
| 2 | $10.96 | 34,658 | $380K | 50.0% |
| Total | $10.96 avg | 69,316 | $760K | 100% |
| Filing → |
| BMEA | SELL | 2023-05-10 | $8.6M | — | Filing → |
| BMEA | SELL | 2023-04-26 | $5.8M | — | Filing → |
| BMEA | SELL | 2023-04-06 | $6.3M | — | Filing → |